Search results
Results from the WOW.Com Content Network
Julio Palmaz was born in December 13, 1945, in La Plata, Argentina; Palmaz's parents were of Italian descent, his father worked as a bus driver. Palmaz received his M.D. in 1971 from the National University of La Plata, Argentina. He joined the San Martin University Hospital in La Plata to practice vascular radiology in 1974.
Stent technology improved rapidly, and in 1989 the Palmaz-Schatz balloon-expandable intracoronary stent was developed. [ 24 ] [ 25 ] Initial results with the Palmaz-Schatz stents were excellent when compared to balloon angioplasty, with a significantly lower incidence of abrupt closure and peri-procedure heart attack. [ 26 ]
It was first used in a human patient by Dr. Ronald Colapinto, of the University of Toronto, in 1982, but did not become reproducibly successful until the development of endovascular stents in 1985. In 1988 the first successful TIPS was realized by M. Rössle, G.M. Richter, G. Nöldge and J. Palmaz at the University of Freiburg. [1]
Johnson & Johnson interventional vascular technology subsidiary Cordis has finished its acquisition of stent maker Flexible Stenting Solutions. Financial terms of the deal weren't disclosed ...
For premium support please call: 800-290-4726 more ways to reach us
Cordis Corporation Announces One-Year Results from the STROLL Trial Trial Assesses the Safety and Efficacy of the S.M.A.R.T.® Nitinol Self-Expandable Stent System in the Superficial Femoral ...
Cordis is an American international medical company that develops and manufactures medical devices for diagnostics and interventional procedures to treat coronary and peripheral vascular diseases. The company operates in the North America, Europe, Middle East, Africa, Asia-Pacific, and Latin America markets.
For premium support please call: 800-290-4726 more ways to reach us